Coumarin compounds show promise for new diabetes treatments by targeting post-meal blood sugar spikes

Scientists discover two coumarin-based molecules that inhibit key enzymes linked to post-meal blood sugar rises, offering potential avenues for novel diabetes therapies. Researchers reporting in Scientific Reports say they have identified two coumarin-based compounds that showed notable activity against enzymes…













